Effect of ACE inhibitor on ACE gene and tau protein expression in neurons.

碩士 === 高雄醫學大學 === 醫學檢驗生物技術學研究所 === 102 === Alzheimer''s disease (AD) is a neurodegenerative disease with progressive loss of neuronal functions, which in turn results in memory deficits, cognitive deterioration, and impaired motor coordination. The growing aged population has led...

Full description

Bibliographic Details
Main Authors: I Chien, 簡薏
Other Authors: Shyh-Jong Wu
Format: Others
Language:zh-TW
Published: 2014
Online Access:http://ndltd.ncl.edu.tw/handle/q2q7qu
id ndltd-TW-102KMC05108003
record_format oai_dc
spelling ndltd-TW-102KMC051080032019-05-15T21:43:13Z http://ndltd.ncl.edu.tw/handle/q2q7qu Effect of ACE inhibitor on ACE gene and tau protein expression in neurons. 探討血管收縮素轉化酶抑制劑對於神經細胞中ACE基因與tau蛋白質表現 I Chien 簡薏 碩士 高雄醫學大學 醫學檢驗生物技術學研究所 102 Alzheimer''s disease (AD) is a neurodegenerative disease with progressive loss of neuronal functions, which in turn results in memory deficits, cognitive deterioration, and impaired motor coordination. The growing aged population has led to an increased prevalence of AD. However, there is no effective treatment to halt the progression or prevent the onset of AD. Previous studies have indicated angiotensin-converting enzyme (ACE) () inhibitor improved the cognitive impairment, but the mechanisms are still unclear. Our previous finding indicated that Alu sequence in human ACE gene possesses a regulatory function on the ACE promoter activity in neurons. Moreover, a previous study indicated that ACE inhibitor enhanced ACE gene expression. We aimed to investigate the pharmacogenetic effect of ACE inhibitors on ACE I/D polymorphism. We used transient transfection and reporter assay to examine the intracellular ACE signaling pathway in SH-SY5Y cells. We find that lisinopril , a ACE inhibitor, enhances ACE promoter transcriptional activity and that the ACE I/D polymorphism differently responds to lisinopril in regulating ACE promoter activity in neurons. The hyper-phosphorylated tau protein has been one of hallmarks for AD. In this study, we also aimed to investigate whether ACE inhibitors regulate hyper-phosphorylated tau protein in neuron and to observe whether the regulators of phosphorylated tau are affected by ACE inhibitors, including GSK3β (glycogen synthase kinase 3 beta), AKT(protein kinase B), PP2A(protein phosphatase 2A). We find that lisinoplril could decrease the hyper-phosphorylation of tau protein induced by okadaic acid. Our results show ACE inhibitors have pharmacogentic effect on ACE gene and might protect neurodegeneration from hyperphosphorlated of tau protein. Shyh-Jong Wu 吳世忠 2014 學位論文 ; thesis 86 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 高雄醫學大學 === 醫學檢驗生物技術學研究所 === 102 === Alzheimer''s disease (AD) is a neurodegenerative disease with progressive loss of neuronal functions, which in turn results in memory deficits, cognitive deterioration, and impaired motor coordination. The growing aged population has led to an increased prevalence of AD. However, there is no effective treatment to halt the progression or prevent the onset of AD. Previous studies have indicated angiotensin-converting enzyme (ACE) () inhibitor improved the cognitive impairment, but the mechanisms are still unclear. Our previous finding indicated that Alu sequence in human ACE gene possesses a regulatory function on the ACE promoter activity in neurons. Moreover, a previous study indicated that ACE inhibitor enhanced ACE gene expression. We aimed to investigate the pharmacogenetic effect of ACE inhibitors on ACE I/D polymorphism. We used transient transfection and reporter assay to examine the intracellular ACE signaling pathway in SH-SY5Y cells. We find that lisinopril , a ACE inhibitor, enhances ACE promoter transcriptional activity and that the ACE I/D polymorphism differently responds to lisinopril in regulating ACE promoter activity in neurons. The hyper-phosphorylated tau protein has been one of hallmarks for AD. In this study, we also aimed to investigate whether ACE inhibitors regulate hyper-phosphorylated tau protein in neuron and to observe whether the regulators of phosphorylated tau are affected by ACE inhibitors, including GSK3β (glycogen synthase kinase 3 beta), AKT(protein kinase B), PP2A(protein phosphatase 2A). We find that lisinoplril could decrease the hyper-phosphorylation of tau protein induced by okadaic acid. Our results show ACE inhibitors have pharmacogentic effect on ACE gene and might protect neurodegeneration from hyperphosphorlated of tau protein.
author2 Shyh-Jong Wu
author_facet Shyh-Jong Wu
I Chien
簡薏
author I Chien
簡薏
spellingShingle I Chien
簡薏
Effect of ACE inhibitor on ACE gene and tau protein expression in neurons.
author_sort I Chien
title Effect of ACE inhibitor on ACE gene and tau protein expression in neurons.
title_short Effect of ACE inhibitor on ACE gene and tau protein expression in neurons.
title_full Effect of ACE inhibitor on ACE gene and tau protein expression in neurons.
title_fullStr Effect of ACE inhibitor on ACE gene and tau protein expression in neurons.
title_full_unstemmed Effect of ACE inhibitor on ACE gene and tau protein expression in neurons.
title_sort effect of ace inhibitor on ace gene and tau protein expression in neurons.
publishDate 2014
url http://ndltd.ncl.edu.tw/handle/q2q7qu
work_keys_str_mv AT ichien effectofaceinhibitoronacegeneandtauproteinexpressioninneurons
AT jiǎnyì effectofaceinhibitoronacegeneandtauproteinexpressioninneurons
AT ichien tàntǎoxuèguǎnshōusuōsùzhuǎnhuàméiyìzhìjìduìyúshénjīngxìbāozhōngacejīyīnyǔtaudànbáizhìbiǎoxiàn
AT jiǎnyì tàntǎoxuèguǎnshōusuōsùzhuǎnhuàméiyìzhìjìduìyúshénjīngxìbāozhōngacejīyīnyǔtaudànbáizhìbiǎoxiàn
_version_ 1719118951781236736